Clinical effect analysis and mechanism study on Qufu Shengjidan for diabetic foot ulcer

Chongqing Orthopaedic Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Aged 18-75 years, gender unlimited;
•2. Patients diagnosed with diabetes mellitus and ulceration, which accords with the classical Wagner grading method of grade 1-3;
•Grade 0: no open lesions, but belongs to high-risk foot; Grade 1: superficial ulcer with skin penetration; Grade 2: deeper ulcer, including ulcers of joints and tendons; Grade 3: deep ulcer, abscess formation, tendon ligament tissue damage; Grade 4: local gangrene and bone destruction; Grade 5: total foot gangrene.
•3. Patients who did not use immunosuppressive agents, or those whose doses of immunosuppressive agents remained unchanged recently;
•4. Sign the informed consent.

•1. diabetic ketoacidosis, non-ketotic hyperosmolar coma patients;
•2. women in lactation and pregnancy;
•3. patients with allergic history or recent allergic diseases to multiple drugs;
•4. patients with severe cardiopulmonary disease, cirrhosis, diabetic nephropathy or more, whose condition is still unstable after active medical treatment;
•5. ulcers caused by malignant tumors;
•6. patients with psychiatric diseases and ignoranceThose who can not express exactly;
•7. those with poor compliance;
•8. those who have participated in other clinical trials of new drugs in the last three months.

发起方

Chongqing Orthopaedic Hospital of Traditional Chinese Medicine